Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Lisata Therapeutics Inc., 3 years.
Lisata Therapeutics Inc.
Director
Xenon Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 9, 2026 | Lisata Therapeutics Inc. | Grant or award | +30,456 | — | — |
| Jan 9, 2025 | Lisata Therapeutics Inc. | Grant or award | +15,789 | — | — |
| Jan 9, 2024 | Lisata Therapeutics Inc. | Grant or award | +19,480 | — | — |
| Dec 19, 2023 | Xenon Pharmaceuticals Inc. | Option exercise | +823 | $9.85 | $8,107 |
| Dec 19, 2023 | Xenon Pharmaceuticals Inc. | Option exercise | +3,497 | $9.85 | $34,445 |
| Jan 9, 2023 | Lisata Therapeutics Inc. | Grant or award | +20,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.